Document is current
Any future updates will be listed below
-
Authors
Ibanez, Laura
Bahena, Jorge A.
Yang, Chengran
Dube, Umber
Farias, Fabiana H. G.
Budde, John P.
Bergmann, Kristy
Brenner-Webster, Carol
Morris, John C.
Perrin, Richard J.
Cairns, Nigel J.
O’Donnell, John
Álvarez, Ignacio
Diez-Fairen, Monica
Aguilar, Miquel
Miller, Rebecca
Davis, Albert A.
Pastor, Pau
Kotzbauer, Paul
Campbell, Meghan C.
Perlmutter, Joel S.
Rhinn, Herve
Harari, Oscar
Cruchaga, Carlos
Benitez, Bruno A. http://orcid.org/0000-0002-2699-3878
-
Funding
Funding for this research was provided by:
National Institute on Aging (P01AG003991, U01AG058922, R01AG057777, RF1AG058501, RF1AG053303, RF1AG044546, P50AG005681, P01AG026276)
National Institute of Neurological Disorders and Stroke (NS075321, NS097437, R01NS097799, R01NS118146)
Alzheimer's Association (NIRG-11-200110, BAND-14-338165, AARG-16-441560, BFG-15-362540)
- License Information
-
More Information
Article History
Received: 2 November 2020
Accepted: 3 November 2020
First Online: 19 November 2020
Ethics approval
: The Institutional Review Boards of all participating institutions approved the study, and this research was carried out in accordance with the recommended protocols. Written informed consent was obtained from participants or their family members.
: CC receives research support from Biogen, EISAI, Alector, and Parabon. The funders of the study had no role in the collection, analysis, or interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. CC is a member of the advisory board of Vivid genetics, Halia Therapeutics, and ADx Healthcare.
